Capping the gastric acid pocket to reduce postprandial acid gastroesophageal reflux

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 12, 2013, Pages 1592-1594

  Sifrim, Daniel ^a   Penagini, Roberto ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; BICARBONATE; CARBON DIOXIDE; PERTECHNETIC ACID TC 99M;

DIAPHRAGM; EDITORIAL; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER; MANOMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERISTALSIS; POSTPRANDIAL ACID REFLUX; POSTPRANDIAL STATE; PULL THROUGH OPERATION; REFLUX ESOPHAGITIS; SCINTIGRAPHY; STOMACH ACID; STOMACH CONTENT; STOMACH JUICE; STOMACH PH;

ALGINATES; ANTACIDS; DRUG CARRIERS; GASTROESOPHAGEAL REFLUX; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS;

EID: 84888012407     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.06.008     Document Type: Editorial

References (30)

1. Sifrim D., Holloway R., Silny J., et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001, 96:647-655.
2. Fisher R.S., Sher D.J., Donahue D., et al. Regional differences in gastric acidity and antacid distribution: is a single pH electrode sufficient?. Am J Gastroenterol 1997, 92:263-270.
3. Caparello C., Bravi I., Cantù P., et al. Traditional vs wireless intragastric pH monitoring: are the two techniques comparable?. Neurogastroenterol Motil 2012, 24. 951-e464.
4. Fletcher J., Wirz A., Young J., et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001, 121:775-783.
5. Goetze O., Treier R., Fox M., et al. The effect of gastric secretion on gastric physiology and emptying in the fasted and fed state assessed by magnetic resonance imaging. Neurogastroenterol Motil 2009, 21. 725-e42.
6. Pandolfino J.E., Schreiner M.A., Lee T.J., et al. Bravo capsule placement in the gastric cardia: a novel method for analysis of proximal stomach acid environment. Am J Gastroenterol 2005, 100:1721-1727.
7. Simonian H., Vo L., Doma S., et al. Regional postprandial differences in pH within the stomach and gastroesophageal junction. Dig Dis Sci 2005, 50:2276-2285.
8. Pandolfino J.E., Zhang Q., Ghosh S.K., et al. Acidity surrounding the squamocolumnar junction in GERD patients: "acid pocket" versus "acid film.". Am J Gastroenterol 2007, 102:2633-2641.
9. Clarke A.T., Wirz A.A., Manning J.J., et al. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket. Gut 2008, 57:292-297.
10. Grigolon A., Cantu P., Bravi I., et al. Subcardial 24-h wireless pH monitoring in gastroesophageal reflux disease patients with and without hiatal hernia compared with healthy subjects. Am J Gastroenterol 2009, 104:2714-2720.
11. Beaumont H., Bennink R.J., de Jong J., et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 2010, 59:441-451.
12. Ghosh S.K., Kahrilas P.J., Brasseur J.G. Liquid in the gastroesophageal segment promotes reflux, but compliance does not: a mathematical modeling study. Am J Physiol Gastrointest Liver Physiol 2008, 295:G920-G933.
13. Kahrilas P.J., McColl K., Fox M., et al. The acid pocket: a target fortreatment in reflux disease?. Am J Gastroenterol 2013, 108:1058-1064.
14. Mandel K.G., Daggy B.P., Brodie D.A., et al. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 2000, 14:669-690.
15. Sweis R., Kaufman E., Anggiansah A., et al. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther 2013, 37:1093-1102.
16. Kwiatek M.A., Roman S., Fareeduddin A., et al. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients. Aliment Pharmacol Ther 2011, 34:59-66.
17. Rohof W.O., Bennink R.J., Smout A.J.P.M., et al. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2013, 11:1585-1591.
18. Zentilin P., Dulbecco P., Savarino E., et al. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther 2005, 21:29-34.
19. Stanciu C., Bennett J.R. Alginate-antacid in the reduction of gastro-oesophageal reflux. Lancet 1974, 1:109-111.
20. Filoche B., Carteret E., Couzigou B., et al. [Randomized double-blind trial with a liquid suspension of alginate for the treatment of pyrosis]. Gastroenterol Clin Biol 1991, 15:984-985.
21. Barnardo D.E., Lancaster-Smith M., Strickland I.D., et al. Adouble-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux. Curr Med Res Opin 1975, 3:388-391.
22. Chatfield S. Acomparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease. Curr Med Res Opin 1999, 15:152-159.
23. Pouchain D., Bigard M.A., Liard F., et al. Gaviscon vs. omeprazole insymptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial. BMC Gastroenterol 2012, 12:18.
24. Manabe N., Haruma K., Ito M., et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial. Dis Esophagus 2012, 25:373-380.
25. Strugala V., Bassin J., Swales V.S., et al. Assessment of the safety andefficacy of a raft-forming alginate reflux suppressant (Liquid Gaviscon) for the treatment of heartburn during pregnancy. ISRN Obstet Gynecol 2012, 2012:481870.
26. Boecxstaens V., Bisschops R., Blondeau K., et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther 2011, 33:1370-1377.
27. Rohof W.O., Bennink R.J., de Ruigh A.A., et al. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut 2012, 61:1670-1677.
28. Curcic J., Schwizer A., Kaufman E. Effect of baclofen on the mechanism of reflux protection in healthy volunteers and patients with gastro-esophageal reflux disease (GERD) assessed by magnetic resonance imaging (MRI) and high-resolution manometry (HRM): arandomized controlled study. Gastroenterology 2012, 142(Suppl 1):S92.
29. Rohof W., Bennink R., Boeckxstaens G.G., et al. Effect of PPIs on the size, position and acidity of the postprandial acid pocket. Gastroenterology 2012, 142(Suppl 1). S92.
30. Herbella F.A., Vicentine F.P., Del Grande J.C., et al. Postprandial proximal gastric acid pocket in patients after laparoscopic Nissen fundoplication. Surg Endosc 2011, 25:3198-3201.